Sort
25,944 grants matching “neurodegeneration”
MITOCHONDRIAL DYSFUNCTION IN NEUROGEGENERATION OF AGING
$1,430,806Winifred Masterson Burke Med Res Inst · P01 · FY2005 · AG
Environmental, Genetic and Cellular Determinants of PD
$1,430,777Parkinson'S Institute · U54 · FY2005 · ES
CEMBRANOIDS AND RNA'S: NEW TOOLS TO STUDY RECEPTORS
$1,430,538Universidad Central Del Caribe · U54 · FY2000 · NS
Remodeling and recovery in the neurovascular unit
$1,430,225Eng H. Lo · Massachusetts General Hospital · P01 · FY2014 · NS
Immunophilin ligands for HIV dementia and neuropathy
$1,429,260Johns Hopkins University · P01 · FY2005 · MH
Implementing a coupled system of integrative ML modeling and data validation for elucidating microglial therapeutic targets in neurodegenerative disease
$1,428,644Karen Sachs · Modulo Bio, Inc. · R44 · FY2024 · MH
Commercialization of Selective Dyrk1a Inhibitors for Down Syndrome
$1,428,499Travis Dunckley · Iluminos Therapeutics, Llc · R44 · FY2025 · NS
Characterizing Cognitive Decline in Late Life Depression: The ADNI-D Project
$1,427,244Robert Scott Mackin · University Of California, San Francisco · R01 · FY2024 · MH
Mu Center for Botanical Interaction Studies
$1,421,849Dennis B Lubahn · University Of Missouri-Columbia · P50 · FY2013 · AT
NHGRI Advanced Imaging & Analysis Core
$1,421,824Stephen Wincovitch · National Human Genome Research Institute · ZIC · FY2024 · HG
Mu Center for Botanical Interaction Studies
$1,421,727Dennis B Lubahn · University Of Missouri-Columbia · P50 · FY2014 · AT
EXCITATORY TRANSMITTERS, MEMORY, AGING AND DEMENTIA
$1,421,585Washington University · P01 · FY2003 · AG
Roles of Cdk5 in neurodevelopment and neurodegeneration
$1,421,288Edward Giniger · National Institute Of Neurological Disorders And Stroke · ZIA · FY2022 · NS
The dynamic architecture of living cells: Uncovering intra-organelle events at nanoscale levels
$1,419,600Yvette Wong · Northwestern University At Chicago · DP2 · FY2021 · GM
Characterizing Cognitive Decline in Late Life Depression: The ADNI-D Project
$1,419,298Robert Scott Mackin · University Of California, San Francisco · R01 · FY2023 · MH
EXCITATORY TRANSMITTERS, MEMORY, AGING AND DEMENTIA
$1,417,485Washington University · P01 · FY2000 · AG
alpha-Synuclein and LRRK2 in the Pathogenesis of Parkinson's Disease
$1,417,153Jie Shen · Brigham And Women'S Hospital · P50 · FY2016 · NS
Preclinical Development of a Selective Suppressor of Neuroinflammation for MCI/AD
$1,416,252Linda J Van Eldik · University Of Kentucky · U01 · FY2015 · AG
Roles of Cdk5 in neurodevelopment and neurodegeneration
$1,416,128Edward Giniger · National Institute Of Neurological Disorders And Stroke · ZIA · FY2025 · NS
Neurovascular Interactions: Mechanisms, imaging, therapeutic potential
$1,415,966Katerina Akassoglou · J. David Gladstone Institutes · R35 · FY2023 · NS
Neurovascular Interactions: Mechanisms, imaging, therapeutic potential
$1,415,966Katerina Akassoglou · J. David Gladstone Institutes · R35 · FY2022 · NS
Neurovascular Interactions: Mechanisms, imaging, therapeutic potential
$1,415,966Katerina Akassoglou · J. David Gladstone Institutes · R35 · FY2021 · NS
Blood Pressure and ADRD in African Americans: the Jackson Heart Study
$1,414,700Priya Palta · Columbia University Health Sciences · R01 · FY2020 · AG
Immunogenetic Determinants of Disease Risk in Neurological Disease
$1,414,582Jorge R. Oksenberg · University Of California, San Francisco · U19 · FY2019 · NS
Innovative Deep Phenotyping of African Americans at Risk for Alzheimers disease
$1,414,551David Loewenstein · University Of Miami School Of Medicine · R01 · FY2023 · AG